| |
| |
|
| Insider
Information: |
Legorreta Pablo G. |
| Relationship: |
CEO, Chairman of the B... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
63,795 |
|
|
Indirect Shares
|
3,312,185 |
|
|
| Direct
Value |
$1,812,416 |
|
|
|
Indirect Value
|
$94,099,176 |
|
|
| Total
Shares |
3,375,980 |
|
|
| Total
Value |
$95,911,592 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Royalty Pharma Plc |
RPRX |
CEO, Chairman of the B... |
2023-11-16 |
63,795 |
2023-11-16 |
3,312,185 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2023-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(383,000) |
63,795 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2023-06-28 |
4 |
B |
$29.51 |
$3,836,768 |
I/I |
130,000 |
600,000 |
2.64 |
% |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2023-06-13 |
4 |
B |
$32.78 |
$1,474,902 |
I/I |
45,000 |
470,000 |
2.64 |
% |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2023-06-12 |
4 |
B |
$33.00 |
$1,484,946 |
I/I |
45,000 |
425,000 |
2.64 |
% |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2023-05-24 |
4 |
B |
$32.25 |
$4,837,440 |
I/I |
150,000 |
380,000 |
2.64 |
% |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2023-05-17 |
4 |
B |
$32.94 |
$2,293,096 |
I/I |
69,612 |
230,000 |
2.64 |
% |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2023-05-16 |
4 |
B |
$33.57 |
$5,383,728 |
I/I |
160,388 |
160,388 |
2.64 |
% |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2022-12-30 |
4 |
GA |
$0.00 |
$0 |
I/I |
292,190 |
292,190 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
2,325,000 |
1,284,590 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
241,810 |
118,500 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
CEO, Chairman of the Board |
• • • |
2020-06-18 |
4 |
B |
$28.00 |
$560,000 |
I/I |
20,000 |
10,000 |
2.64 |
% |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
